Stress Challenge for Myocardial Ischemia
(MIMS3 Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to look at the link between emotional stress and heart disease in men and women. Taking part in this study involves one clinic visit, one week of at home monitoring, and follow up phone calls every 6 months for 3 years.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications, but it mentions that anti-ischemic medications are typically paused before imaging studies. If you are on psychotropic medications (except anti-depressants), you may need to stop them as they are excluded if taken in the past month.
What data supports the effectiveness of the treatment Stress Challenge for myocardial ischemia?
Research shows that mental stress can trigger myocardial ischemia (reduced blood flow to the heart) in patients with coronary artery disease, similar to how physical exercise does. Managing stress effectively could potentially help in reducing the risk of future heart problems in these patients.12345
Is the Stress Challenge for Myocardial Ischemia safe for humans?
The studies reviewed indicate that mental stress can induce myocardial ischemia (reduced blood flow to the heart) in patients with coronary artery disease, similar to exercise stress tests. However, the safety of mental stress testing itself is not directly addressed, and it appears to be used as a diagnostic tool rather than a treatment.36789
How does the stress challenge treatment for myocardial ischemia differ from other treatments?
The stress challenge treatment for myocardial ischemia is unique because it uses mental stress tasks, like public speaking, to induce ischemia, which can occur at lower heart rates compared to exercise-induced ischemia. This approach highlights the role of emotional stress in triggering silent ischemic events, offering a novel way to study and potentially manage myocardial ischemia in patients with coronary artery disease.210111213
Research Team
Viola Vaccarino, MD, PhD
Principal Investigator
Emory University
Eligibility Criteria
This trial is for men and women aged 60 or younger who had a heart attack within the last 8 months. It's not suitable for those with recent severe heart issues, high blood pressure on test day, current use of certain psychotropic drugs (except antidepressants), pregnant or breastfeeding women, people over 360 pounds or with a BMI of 40+, and individuals with other serious health problems.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Stress Challenge and Monitoring
Participants undergo a stress challenge to assess mental stress-induced myocardial ischemia (MSI) and are monitored at home for 1 week
Follow-up
Participants are monitored for clinical events and outcomes related to MSI status through follow-up phone calls every 6 months
Treatment Details
Interventions
- Stress Challenge
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator